John R. Grigg

John R. Grigg

MB BS; MD; FRANZCO; FRACS

Ophthalmologist

about 40 years of Experience

Male📍 Sydney

About of John R. Grigg

John R. Grigg is an ophthalmologist based in Sydney, working out of 8 Macquarie St, Sydney, NSW 2000, Australia.


He looks after people with a wide range of eye problems, from day-to-day vision issues to more serious eye conditions. Many of his patients come in with things like cataracts and glaucoma, and others need help with retinal problems such as age-related macular degeneration, diabetic retinopathy, and retinal detachment. At times he also sees patients with uveitis and issues that affect the optic nerve.


Over time, he has built a strong practice across both medical and surgical eye care. Depending on what is going on, care may include procedures for cataracts, and eye surgery when needed for conditions like glaucoma and retinal disease. He also works with treatments such as vitrectomy and trabeculectomy, and manages blocked tear duct problems and other eye surface concerns when they fit the bigger picture.


For people with long-term or inherited eye conditions, he can be part of the team that supports ongoing vision management. This can include retinitis pigmentosa and other retinal degenerations, as well as conditions that affect the macula and how the eye develops. In some cases, he also treats children and young adults for eye problems like amblyopia, plus childhood-onset conditions that need careful follow-up.


John has around 40 years of experience. That kind of time in the field helps with the “what matters most” part of eye care, because every case is a bit different and patients do not always fit the usual pattern.


His qualifications include MB BS and MD degrees, plus specialist fellowships: FRANZCO for Fellowship in Specialist Ophthalmology and FRACS through the Royal Australasian College of Surgeons.


He has also been involved in medical publications over the years, which helps keep practice grounded in the latest evidence and experience.


If you are dealing with a change in vision, eye pain, or ongoing eye disease, he focuses on clear explanations and practical next steps, so you know what is happening and what the plan is.

Education

  • MB BS, Medicine (primary medical degree); University of Queensland; 1985
  • MD - Doctor of Medicine; University of Sydney; 2011
  • FRANZCO, Fellowship — Specialist Ophthalmology; Royal Australian & NZ College of Ophthalmologists
  • FRACS, Fellowship — Royal Australasian College of Surgeons; Royal Australasian College of Surgeons

Services & Conditions Treated

Retinopathy Pigmentary Mental RetardationCongenital CataractLate-Onset Retinal DegenerationRetinitis PigmentosaAge-Related Macular Degeneration (ARMD)Birdshot ChorioretinopathyCataractCataract RemovalCone-Rod DystrophyGlaucomaMicrophthalmiaOcular Hypertension (OHT)Phosphoglycerate Kinase DeficiencyStargardt Macular DegenerationTrabeculectomyVitrectomyX-Linked Retinitis Pigmentosa (XLRP)Adult-Onset Vitelliform Macular Dystrophy (AVMD)AmblyopiaAnhidrosisAniridiaAstigmatismAxenfeld-Rieger SyndromeBatten DiseaseBlocked Tear DuctBrown SyndromeColobomaCone DystrophyDiabetic RetinopathyGanglion CystHearing LossIridogoniodysgenesis Type 1Kearns-Sayre SyndromeLeber Congenital AmaurosisMetastatic Uveal MelanomaMucopolysaccharidosis Type 7 (MPS VII, Sly Syndrome)Neurofibromatosis Type 2 (NF2)Optic Nerve AtrophyParkes Weber SyndromePigment-Dispersion SyndromeProgressive External OphthalmoplegiaRetinal Artery OcclusionRetinal DetachmentSplenomegalySturge-Weber SyndromeUsher SyndromeUveitisX-Linked Infantile Nystagmus

Publications

5 total
Phototransduction in the Genomic Era: Mechanisms, Genetics and Therapeutic Advances.

Clinical & experimental ophthalmology • February 24, 2025

John Grigg, Robyn Jamieson

Longitudinal study in autosomal recessive PROM1 inherited retinal disease.

Ophthalmic Genetics • June 10, 2025

William Yates, John Grigg, Benjamin Nash, Alan Ma, Sulekha Rajagopalan, Bernadette Hanna, Robyn Jamieson

PROM1 inherited retinal diseases (IRDs) result in significant phenotypic heterogeneity ranging from macular dystrophy to severe rod-cone dystrophy. This study examined a cohort of patients with autosomal recessive (AR) PROM1-associated IRD to determine important potential biomarkers of disease progression on multimodal imaging. Ophthalmic phenotyping included clinical examination, OCT, fundus autofluorescence and electrophysiology. The cohort included six patients with bi-allelic variants, including two novel variants, and a median of 11.8 years of follow-up. Best-corrected visual acuity (BCVA) was maintained until a steep decline around 15 years of age. This was preceded by contraction of the subfoveal ellipsoid zone length (EZL), measured on OCT. Review of the literature demonstrated that cone or cone-rod dystrophy was the most frequently identified clinical phenotype. Loss of function variants including nonsense, frameshift and splice variants were particularly common. This study provides detailed insights into the natural history of AR PROM1 IRD and current understanding in the published literature. Contraction of the subfoveal EZL appears to be a potential biomarker for disease progression and occurs earlier than reduction in BCVA.

A Practical Guide to Genetic Eye Conditions for Paediatricians.

Journal Of Paediatrics And Child Health • April 02, 2025

Richard Lin, Alan Ma, Benjamin Nash, Zachary Mcpherson, John Grigg, Robyn Jamieson

Background: Inherited eye disorders, though individually rare, are a collectively common cause of paediatric vision impairment. Many occur as part of a syndrome, in association with congenital anomalies and/or growth/developmental disorders. Paediatricians are well placed to recognise ocular disorders and syndromic associations, and help facilitate appropriate investigations and referrals, including genetic testing. Timely recognition of these conditions may allow patients to capitalise on the recent advances in ocular genetic therapy and clinical trials which are progressing for both non-syndromic and syndromic ocular conditions. Objective: This review provides a practical guide for paediatricians on recognising genetic eye conditions in children, initiating appropriate investigations, and referring for genetic testing. Methods: An overview of the most common Mendelian paediatric eye conditions and their syndromic associations is provided, encompassing disorders which affect the anterior and/or posterior segments. A suggested framework including a flowchart for recognising potentially inherited ocular conditions and recognising syndromic diagnoses is included. Finally, a discussion regarding the utility of a genetic diagnosis, including information about inheritance, genetic counselling, and current gene therapy and clinical trials is provided. Conclusions: Genetic eye conditions are an important cause of ocular morbidity in children. These conditions may be isolated to the eye or have multisystem syndromic associations. Additionally, in an era where genetic testing is increasingly being mainstreamed and given the availability of gene therapy, it is relevant for paediatricians to be familiar with genetic eye conditions. This review provides a practical approach for paediatricians to help navigate these conditions.

Understanding the phenotype of genetically associated electronegative ERG retinopathies: comparing the full-field ERG b:a ratio.

Graefe's Archive For Clinical And Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie • January 21, 2025

Christopher Ovens, Elisa Cornish, Haipha Ali, Vannessa Leung, Dhimas Sakti, Nonna Saakova, Marium Raza, Benjamin Nash, Clare Fraser, Peter Mccluskey, Robyn Jamieson, John Grigg

Objective: The electronegative electroretinogram (ERG) is a specific clinical finding usually indicating inner retinal dysfunction occurring post-phototransduction. X-linked retinoschisis (XLRS) and complete and incomplete congenital stationary night blindness (cCSNB, iCSNB) are inherited retinal dystrophies classically associated with electronegative ERGs. Comparing the full-field ERG b:a ratio expands current ERG diagnostic criteria and aids in localising physiological sites and pathological mechanisms. Methods: A retrospective review of patients with a clinical diagnosis of iCSNB, cCSNB and XLRS was conducted. ERG and genetic results were analysed. Average b:a ratios between groups were compared, and prevalence of electropositivity was assessed using thresholds of b:a > 1.0 and b:a > 1.50. Results: 53 patients were included, and genetic confirmation was available in 7/24 iCSNB, 3/14 cCSNB and 11/15 XLRS patients respectively. In genetically proven cases, mean b:a ratio in XLRS patients (b:a = 1.04) was significantly higher than cCSNB (b:a = 0.60, p < 0.001) and iCSNB (b:a = 0.60, p < 0.001). An electropositive ERG was significantly more likely to be associated with RS1 than iCSNB (p < 0.001) or cCSNB (p = 0.001) at b:a > 1.0 threshold, and more likely RS1 than iCSNB (p = 0.040) at b:a > 1.5 threshold. Conclusions: Our study highlights the distinct ERG findings between these typically electronegative inner retinal dystrophies. In a clinical setting, the traditional electronegative definition of b:a < 1.0 appears very insensitive to detect XLRS patients. Our data suggests clinical suspicion should remain even in patients with a b:a ratio > 1.50, and highlights the importance of genetic testing in these cases.

Detecting congenital chiasmal misrouting using multichannel VEPs: protocol for a scoping review.

Documenta Ophthalmologica. Advances In Ophthalmology • January 21, 2025

Giulia Steuernagel Del Valle, Haipha Ali, John Grigg, Ruth Hamilton, Michael Hoffmann, Bruce Hudson, Wanda Pfeifer, Dorothy Thompson, Anupreet Tumber, Ajoy Vincent, Gerard De Wit

Objective: We present the protocol of a prospective scoping review which aims to understand how multi-channel visual evoked potentials (mcVEPs) are used to investigate congenital chiasmal misrouting and what outcomes are measured, interpreted and reported. Background: mcVEPs are used for the objective evaluation of chiasmal misrouting, which is characterized by a crossed asymmetry in the distribution of cortical responses over each hemisphere during monocular stimulation, and is often observed in patients with albinism. The application and analysis of mcVEPs varies across centers, creating a need to explore the range of practice regarding their conduct and reporting and to identify potential areas for adaptation or optimization or guidelines for specific populations. Methods: Peer reviewed and grey literature on the use of mcVEP to detect chiasmal misrouting in humans with non-acquired pathologies will be considered. All literature providing details of mcVEP methodology for replication and specification of chiasmal misrouting will be included for review. Methods: Searches will be conducted using MEDLINE, Embase, Cochrane and Web of Science with the expertise of a librarian. The search will be conducted with no limitation on time period, but will be restricted to the Latin alphabet. Titles and abstracts will be screened by two investigators with conflicts resolved by a third investigator. Included articles will proceed with data extraction on study details including methodology, design, and outcomes. The results will be synthesized and mapped for logical understanding.

Frequently Asked Questions

What services does Dr John R. Grigg provide?
Dr Grigg is an ophthalmologist offering a range of eye care services, including cataract assessment and removal, glaucoma management, retinal conditions such as age-related macular degeneration and retinitis pigmentosa, and vitrectomy. He also treats other eye issues listed in his services, like ocular hypertension and various retinal dystrophies.
What conditions does Dr Grigg treat?
He treats a wide array of eye conditions, including cataracts, glaucoma, retinal diseases (e.g., AMD, retinitis pigmentosa, cone-rod dystrophy), uveitis, and optic nerve problems. The list also covers inherited or complex eye conditions and related ocular surface issues noted in his services.
How do I book an appointment with Dr Grigg?
To book an appointment, contact his practice at 8 Macquarie St, Sydney, NSW 2000, Australia. Please follow the practice’s booking process to arrange a consult or procedure.
What should I expect at my first visit?
At the first visit, you’ll have an eye examination and discuss your symptoms, medical history and any eye conditions you’re concerned about. The doctor will determine if tests or imaging are needed and outline a plan for your eye health.
Does Dr Grigg perform cataract surgery and other eye operations?
Yes. The services list includes cataract removal and other procedures such as trabeculectomy and vitrectomy as part of managing eye health and specific conditions.
What languages are available for consultation?
The profile lists no specific languages, but the medical team can typically arrange appropriate language support as needed. Please check with the practice when booking.

Contact Information

8 Macquarie St, Sydney, NSW 2000, Australia

Is this your profile?

Claim this profile →

Memberships

  • FRANZCO, Fellowship — Specialist Ophthalmology, Royal Australian & NZ College of Ophthalmologists
  • FRACS, Fellowship — Royal Australasian College of Surgeons
  • Retina Australia’s Research Grants Advisory Committee